Novel genetic variants in tuberculosis-associated immune reconstitution inflammatory syndrome [0.03%]
与结核病相关的免疫重建炎症综合征中的新型遗传变异体
Cecilia Wieder,Stuart Horswell,Gavin Kelly et al.
Cecilia Wieder et al.
Extracellular Vesicle Cargo from Lipofibroblasts Mitigates COPD by Alveolar Type II Cell Restoration [0.03%]
来自脂质纤维母细胞的细胞外囊泡货物通过II型肺泡上皮细胞再生缓解慢性阻塞性肺疾病
Shota Fujimoto,Yuta Hirano,Kazuki Kawajiri et al.
Shota Fujimoto et al.
Rationale: Emerging research highlights cellular abnormalities in Chronic Obstructive Pulmonary Disease (COPD), focusing on alveolar type 2 (AT2) cells, which are key to lung tissue repair and normal cellular differentiat...
The CFTR potentiator Icenticaftor for treatment of bronchiectasis: An international phase 2, double-blind, randomized placebo-controlled trial [0.03%]
一项国际性Ⅱ期、双盲、随机安慰剂对照试验评估CFTR功能增强型药物Icenticaftri治疗支气管扩张症的效果
Wei-Jie Guan,Charles S Haworth,Harm A W M Tiddens et al.
Wei-Jie Guan et al.
Predicting response to immunosuppression in non-IPF ILDs: Can molecular endotyping lead the way? [0.03%]
预测非特发性肺纤维化间质性肺病对免疫抑制的反应：分子分型可以引领方向吗？
Jeffrey A Sparks,Barry S Shea
Jeffrey A Sparks
Reply to Yang and Zeng: Durability or Bias? Reconsidering Long-term ELX/TEZ/IVA Outcomes in Children with CF [0.03%]
杨氏和曾氏致信的回应：耐用性还是偏倚？儿童囊性纤维化患者长期ELX / TEZ / IVA结局的再思考
Claire Wainwright,Susanna A Mccolley,Jane C Davies;VX-- Study Group
Claire Wainwright
Hamid Merdji,Anaïs Curtiaud,Clément Delmas et al.
Hamid Merdji et al.
Monoclonal antibody therapy in COPD: will it prevent hospitalisations? [0.03%]
单克隆抗体治疗在COPD中的应用：能否预防住院治疗？
Sharon W L Lam,Lalitha Menon,Justin Y Goh et al.
Sharon W L Lam et al.
Emerging yet complex role of fetal lung macrophages in patients with congenital diaphragmatic hernia [0.03%]
先天性膈疝患者胎儿肺巨噬细胞的作用复杂而又重要
Fabian Doktor,Lina Antounians,Rebeca Lopes Figueira et al.
Fabian Doktor et al.
Reply to Wang et al.: Causal Inference Considerations in Proteomic Biomarker Studies for Interstitial Lung Disease [0.03%]
对王等人观点的回应：因果推理在间质性肺疾病蛋白组生物标志物研究中的考虑因素
John S Kim,Catherine L Debban,Ani Manichaikul
John S Kim